Chargement en cours...
Omadacycline Enters the Ring: A New Antimicrobial Contender
Omadacycline is a novel aminomethylcycline approved for the treatment of community‐acquired bacterial pneumonia and acute bacterial skin and skin structure infections. This article reviews existing data pertaining to the biochemistry, mechanism of action, pharmacokinetics/pharmacodynamics, in vitro...
Enregistré dans:
| Publié dans: | Pharmacotherapy |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587716/ https://ncbi.nlm.nih.gov/pubmed/30290000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.2185 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|